Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

UCB, Biogen lupus drug scores in phase 3 trial
Pharmaphorum
Tuesday, September 24, 2024 - 11:37am
tags:
UCB Pharma, Biogen, systemic lupus erythematosus, clinical trials, dapirolizumab pegol
Bluebird bio lays off 25% of workforce as gene therapy pioneer struggles to stay afloat
Fierce Pharma
Tuesday, September 24, 2024 - 11:35am
tags:
Bluebird Bio, layoffs, gene therapy
Sanofi CEO believes company poised for growth from new drugs
Reuters
Monday, September 23, 2024 - 10:32pm
tags:
Sanofi, Pharma CEOs, Paul Hudson
Novo says Ozempic to be eligible for US price negotiations in less than a year
Reuters
Monday, September 23, 2024 - 10:27pm
tags:
Novo Nordisk, Ozempic, drug pricing
Johnson & Johnson Files for Bankruptcy Over Talc Lawsuits for the Third Time
Yahoo/Zacks.com
Monday, September 23, 2024 - 10:25pm
tags:
JNJ, legal, bankruptcy
Startup Vicebio banks $100M in bid to make ‘cost-effective’ vaccines
BioPharma Dive
Monday, September 23, 2024 - 10:24pm
tags:
Vicebio, vaccines, funding
UCB rapidly bolsters blockbuster potential for Bimzelx with 3 new FDA approvals
Fierce Pharma
Monday, September 23, 2024 - 10:19pm
tags:
UCB Pharma, Bimzelx, FDA, psoriatic arthritis, radiographic axial spondyloarthritis, ankylosing spondylitis
Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M
Fierce Biotech
Monday, September 23, 2024 - 11:33am
tags:
Sanofi, Ventyx Biosciences, obesity, Parkinson's Disease
Appeals Court Breathes New Life Into PhRMA’s Legal Challenge to IRA
BioSpace
Monday, September 23, 2024 - 11:31am
tags:
PhRMA, legal, Inflation Reduction Act, drug pricing
AstraZeneca's experimental drug disappoints in breast cancer survival trial
Reuters
Monday, September 23, 2024 - 11:29am
tags:
AstraZeneca, Daiichi Sankyo, clinical trials, breast cancer, Dato-DXd
Teva touts safety profile of once-monthly schizophrenia therapy
Clinical Trials Arena
Monday, September 23, 2024 - 11:17am
tags:
Teva Parmceuticals, TEV-749, Olanzapine, schizophrenia
Imaging agent developer Telix to buy RLS radiopharmaceutical network for up to $250M
Radiology Business
Monday, September 23, 2024 - 9:56am
tags:
Telix Pharmaceuticals. M&A, RLS, radiopharmaceuticals
J&J hopes 3rd time's the charm for Texas two-step strategy as it lifts talc settlement offer to $8B
Fierce Pharma
Monday, September 23, 2024 - 9:51am
tags:
JNJ, legal
Patient access: How Novartis, Eli Lilly, and other Big Pharmas measure up
Pharma Voice
Monday, September 23, 2024 - 9:50am
tags:
Big Pharma, patient access
Novo Nordisk faces US congressional grilling over price of weight loss drugs
Reuters
Monday, September 23, 2024 - 9:49am
tags:
Novo Nordisk, Senate, Bernie Sanders, Ozempic, drug pricing
Biohaven's genetic disease drug meets main trial goal
Reuters
Monday, September 23, 2024 - 9:48am
tags:
Biohaven, troriluzole, spinocerebellar ataxia, clinical trials
FDA clears first drug for Niemann-Pick disease
Pharmaphorum
Monday, September 23, 2024 - 9:47am
tags:
Zevra Therapeutics, Miplyffa, FDA, Niemann-Pick disease
With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine
Fierce Pharma
Sunday, September 22, 2024 - 9:49pm
tags:
AstraZeneca, FluMist, vaccines, FDA
Daiichi Sankyo launches first DTC ad for Enhertu, representing shift toward patient-centric oncology campaigns
Medical Marketing and Media
Sunday, September 22, 2024 - 9:46pm
tags:
Daiichi Sankyo, AstraZeneca, breast cancer, metastatic breast cancer, Enhertu, DTC ads
Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa
Fierce Pharma
Sunday, September 22, 2024 - 9:44pm
tags:
Sanofi, Sarclisa, FDA, Multiple Myeloma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.